- FDA commercial approval.
- The largest biotech deal done in this country.
- Another US$87m in the bank (to go with the US$50m)
- Royalties of 15%+ on global sales
- up to US$195m in milestone payments
- Eli Lilly to market and distribute
- US market worth US$1b pa and growing at 20%pa (this is just US)
- Conceivable they could get 35% market share.
- will commence paying a dividend in 2011.
- Potential to make a 50c per share special dividend.
And best of all, all dividends and capital gains are tax free due to pooled development fund status.
It will not be too long before the institutions line up to buy this. Expect strong media coverage to come.
$4-$5+ written all over it.
- FDA commercial approval.- The largest biotech deal done in...
-
- There are more pages in this discussion • 22 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add ACR (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
6.5¢ |
Change
0.000(0.00%) |
Mkt cap ! $18.89M | |||
| Open | High | Low | Value | Volume |
| 0.0¢ | 0.0¢ | 0.0¢ | $0 | 0 |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 1 | 3903 | 6.2¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 6.4¢ | 100000 | 1 |
View Market Depth
| Last trade - 16.12pm 12/07/2024 (20 minute delay) ? |
| ACR (ASX) Chart |
Day chart unavailable